[丝裂霉素C、异环磷酰胺和长春地辛用于非小细胞支气管癌的联合化疗]
[Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
作者信息
Laumen R, Jungbluth H, von Pawel J, Häussinger K, Otto M, Krieger H
机构信息
Klinik Seltersberg, Giessen der LVA-Hessen.
出版信息
Pneumologie. 1990 Feb;44 Suppl 1:590.
PMID:2164206
Abstract
The results of antineoplastic polychemotherapy in non-small-cell carcinomas of the lungs revealed on overall remission rate of 42.1%, with a distribution from limited to extensive disease of approximately 32% to 58%. Severe undesired side effects of the treatment were not observed, the duration of remission was, on average, 78 days, and the survival period 101 days.
摘要
对非小细胞肺癌进行多药联合化疗的结果显示，总体缓解率为42.1%，从局限性疾病到广泛性疾病的分布约为32%至58%。未观察到该治疗的严重不良副作用，缓解期平均为78天，生存期为101天。
相似文献
1
[Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].[丝裂霉素C、异环磷酰胺和长春地辛用于非小细胞支气管癌的联合化疗]
Pneumologie. 1990 Feb;44 Suppl 1:590.
2
3
4
[Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].丝裂霉素C、长春地辛和顺铂联合化疗（MVP疗法）治疗晚期非小细胞肺癌的临床研究
Gan To Kagaku Ryoho. 1989 Jul;16(7):2399-403.
5
European experience with ifosfamide in non-small cell lung cancer.欧洲使用异环磷酰胺治疗非小细胞肺癌的经验。
Semin Oncol. 1989 Feb;16(1 Suppl 3):22-30.
6
Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
Singapore Med J. 1998 Aug;39(8):357-8.
7
8
[Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].[顺铂、长春地辛和丝裂霉素C联合化疗治疗非小细胞肺癌]
Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 1):1455-60.
9
Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.异环磷酰胺、丝裂霉素和顺铂联合化疗用于晚期非小细胞肺癌
Cancer Treat Rep. 1987 Sep;71(9):851-3.
10
[Combination chemotherapy with bronchial arterial infusion (BAI) and systemic chemotherapy in advanced non-small cell lung cancer].[支气管动脉灌注（BAI）联合全身化疗治疗晚期非小细胞肺癌]
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2697-700.
Zotero 插件